Top

Osteoporosis International

Published in:

01-11-2017 | Original Article

Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies

Authors: F.-L. Liu, C.-S. Lin, C.-C. Yeh, C.-C. Shih, Y.-G. Cherng, C.-H. Wu, T.-L. Chen, C.-C. Liao

Published in: Osteoporosis International | Issue 11/2017

Abstract

Summary

Using national insurance claims data of Taiwan, we found that patients with peripheral arterial disease (PAD) had increased risk of fracture during the follow-up period of 2000–2013. History of PAD was also associated with adverse outcomes in hospitalized fracture patients. Prevention strategies were needed in this susceptible population.

Introduction

Limited information was available on the association between PAD and fracture. The purpose of this study is to evaluate fracture risk and post-fracture outcomes in patients with PAD.

Methods

We identified 6647 adults aged ≥ 20 years with newly diagnosed PAD using the Taiwan National Health Insurance Research Database in 2000–2004. Comparison cohort consisted of 26,588 adults without PAD randomly selected with frequency matching in age and sex. Events of fracture were identified during the follow-up period from January 1, 2000 until December 31, 2013, to evaluate adjusted hazard ratios (HR) and 95% confidence interval (CI) of fracture associated with PAD. Another nested cohort study of 799,463 hospitalized fracture patients analyzed adjusted odds ratios (ORs) and 95% CIs of adverse events after fracture among patients with and without PAD in 2004–2013.

Results

Incidences of fracture in people with and without PAD were 22.1 and 15.5 per 1000 person-years, respectively (P < .0001). Compared with control, the adjusted HR of fracture was 1.59 (95% CI, 1.48–1.69) for PAD patients. In the nested cohort study, patients with PAD had higher post-fracture mortality (OR = 1.16; 95% CI, 1.09–1.25) and various complications. PAD patients also had comparatively higher medical expenditure (2691 vs. 2232 USD, P < .0001) and longer hospital stay (10.6 vs. 9.0 days, P < 0.0001) during fracture admission.

Conclusions

Increased risk of fracture and post-fracture adverse outcomes were associated with PAD. This susceptible population needs care to prevent fracture and to minimize adverse outcomes after it occurs.

Nowygrod R, Egorova N, Greco G et al (2006) Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg 43:205–216CrossRefPubMed

Hirsch AT, Hartman L, Town RJ, Virnig BA (2008) National health care costs of peripheral arterial disease in the Medicare population. Vasc Med 13:209–215CrossRefPubMed

Krupski WC, Layug EL, Reilly LM, Rapp JH, Mangano DT (1992) Comparison of cardiac morbidity between aortic and infrainguinal operations. Study of Perioperative Ischemia (SPI) Research Group. J Vasc Surg 15:354–363CrossRefPubMed

McDermott MM, Greenland P, Liu K et al (2001) Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 286:1599–1606CrossRefPubMed

Gardner AW, Montgomery PS (2001) Impaired balance and higher prevalence of falls in subjects with intermittent claudication. J Gerontol A Biol Sci Med Sci 56:M454–M458CrossRefPubMed

Mangiafico RA, Russo E, Riccobene S et al (2006) Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women. J Bone Miner Metab 24:125–131CrossRefPubMed

Collins TC, Ewing SK, Diem SJ et al (2009) Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men. Circulation 119:2305–2312CrossRefPubMedPubMedCentral

Hyde Z, Mylankal KJ, Hankey GJ, Flicker L, Norman PE (2013) Peripheral arterial disease increases the risk of subsequent hip fracture in older men: the Health in Men Study. Osteoporos Int 24:1683–1688CrossRefPubMed

Von Mühlen D, Allison M, Jassal SK, Barrett-Connor E (2009) Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study. Osteoporos Int 20:2071–2078CrossRef

10.

Peláez VC, Ausín L, Ruiz Mambrilla M, Gonzalez-Sagrado M, Pérez Castrillón JL (2015) Ankle-brachial index, risk of clinical fractures, mortality and low bone mass in nursing home residents. Eur Rev Med Pharmacol Sci 19:1577–1582PubMed

11.

Liao CC, Lin CS, Shih CC et al (2014) Increased risk of fracture and postfracture adverse events in patients with diabetes: two nationwide population-based retrospective cohort studies. Diabetes Care 37:2246–2252CrossRefPubMed

12.

Huang YF, Cherng YG, Hsu SP et al (2015) Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies. Osteoporos Int 26:1723–1732CrossRefPubMed

13.

Court-Brown CM, Caesar B (2006) Epidemiology of adult fractures: a review. Injury 37:691–697CrossRefPubMed

14.

Stehman-Breen CO, Sherrard DJ, Alem AM et al (2000) Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200–2205CrossRefPubMed

15.

Guilley E, Herrmann F, Rapin CH, Hoffmeyer P, Rizzoli R, Chevalley T (2011) Socioeconomic and living conditions are determinants of hip fracture incidence and age occurrence among community-dwelling elderly. Osteoporos Int 22:647–653CrossRefPubMed

16.

Sennerby U, Melhus H, Gedeborg R et al (2009) Cardiovascular diseases and risk of hip fracture. JAMA 302:1666–1673CrossRefPubMed

17.

Ensrud KE (2013) Epidemiology of fracture risk with advancing age. J Gerontol A Biol Sci Med Sci 68:1236–1242CrossRefPubMed

18.

Black DM, Rosen CJ (2016) Clinical practice: postmenopausal osteoporosis. N Engl J Med 374:254–262CrossRefPubMed

19.

Gregson CL, Dennison EM, Compston JE et al (2014) Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study. Osteoporos Int 25:85–95CrossRefPubMed

20.

Hsu CC, Hsu YC, Chang KH, Lee CY, Chong LW, Wang YC, Hsu CY, Kao CH (2016) Increased risk of fracture in patients with bipolar disorder: a nationwide cohort study. Soc Psychiatry Psychiatr Epidemiol 51:1331–1338CrossRefPubMed

21.

Bang UC, Benfield T, Bendtsen F, Hyldstrup L, Beck Jensen JE (2014) The risk of fractures among patients with cirrhosis or chronic pancreatitis. Clin Gastroenterol Hepatol 12:320–326CrossRefPubMed

22.

Nickolas TL, Leonard MB, Shane E (2008) Chronic kidney disease and bone fracture: a growing concern. Kidney Int 74:721–731CrossRefPubMedPubMedCentral

23.

Ouriel K (2001) Peripheral arterial disease. Lancet 358:1257–1264CrossRefPubMed

24.

Fowkes FG, Rudan D, Rudan I et al (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382:1329–1340CrossRefPubMed

25.

Vogt MT, Cauley JA, Kuller LH, Nevitt MC (1997) Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures. J Bone Miner Res 12:283–289CrossRefPubMed

26.

Szulc P, Blackwell T, Schousboe JT et al (2014) High hip fracture risk in men with severe aortic calcification: MrOS study. J Bone Miner Res 29:968–975CrossRefPubMedPubMedCentral

27.

Bagger YZ, Tankó LB, Alexandersen P, Qin G, Christiansen C (2006) Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. J Intern Med 259:598–605CrossRefPubMed

28.

Sathiyakumar V, Avilucea FR, Whiting PS et al (2016) Risk factors for adverse cardiac events in hip fracture patients: an analysis of NSQIP data. Int Orthop 40:439–445CrossRefPubMed

29.

Belmont PJ Jr, Davey S, Rensing N, Bader JO, Waterman BR, Orr JD (2015) Patient-based and surgical risk factors for 30-day postoperative complications and mortality after ankle fracture fixation. J Orthop Trauma 29:e476–e482CrossRefPubMed

30.

Rossi E, Biasucci LM, Citterio F et al (2002) Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation 105:800–803CrossRefPubMed

31.

Mittalhenkle A, Gillen DL, Stehman-Breen CO (2004) Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis 44:672–679CrossRefPubMed

32.

Pouwels S, Lalmohamed A, Leufkens B et al (2009) Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke 40:3281–3285CrossRefPubMed

33.

Laroche M, Pouilles JM, Ribot C et al (1994) Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol 13:611–614CrossRefPubMed

34.

Fahrleitner-Pammer A, Obernosterer A, Pilger E et al (2005) Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease. Osteoporos Int 16:319–324CrossRefPubMed

35.

Fahrleitner A, Dobnig H, Obernosterer A et al (2002) Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J Gen Intern Med 17:663–669CrossRefPubMedPubMedCentral

36.

Laghi Pasini F, Pastorelli M, Beermann U et al (1996) Peripheral neuropathy associated with ischemic vascular disease of the lower limbs. Angiology 47:569–577CrossRefPubMed

37.

Gardner AW, Montgomery PS (2001) The relationship between history of falling and physical function in subjects with peripheral arterial disease. Vasc Med 6:223–227CrossRefPubMed

38.

Ghanami RJ, Hurie J, Andrews JS et al (2013) Anesthesia-based evaluation of outcomes of lower-extremity vascular bypass procedures. Ann Vasc Surg 27:199–207CrossRefPubMed

39.

Gracious BL, Fontanella CA, Phillips GS, Bridge JA, Marcus SC, Campo JV (2016) Antidepressant exposure and risk of fracture among Medicaid-covered youth. J Clin Psychiatry 77:e950–e956CrossRefPubMed

40.

Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:807–816CrossRefPubMed

Title: Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies
Authors: F.-L. Liu
C.-S. Lin
C.-C. Yeh
C.-C. Shih
Y.-G. Cherng
C.-H. Wu
T.-L. Chen
C.-C. Liao
Publication date: 01-11-2017
Publisher: Springer London
Published in: Osteoporosis International / Issue 11/2017
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-017-4192-z

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies

Abstract

Summary

Introduction

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2017

Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG)

Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years’ experience in a single center

Increased levels of sodium chloride directly increase osteoclastic differentiation and resorption in mice and men

The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the United States: supplementary presentation

Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature

Interventions for humeral shaft fractures: mixed treatment comparisons of clinical trials